Dental staining after doxycycline use in children

被引:46
作者
Poyhonen, Heidi [1 ]
Nurmi, Mirka [2 ]
Peltola, Ville [1 ]
Alaluusua, Satu [3 ]
Ruuskanen, Olli [1 ]
Lahdesmaki, Tuire [1 ,4 ,5 ]
机构
[1] Turku Univ Hosp, Dept Paediat & Adolescent Med, Turku, Finland
[2] Turku Univ Hosp, Dept Oral & Maxillofacial Dis, Turku, Finland
[3] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland
[4] Turku Univ Hosp, Dept Paediat Neurol, Turku, Finland
[5] Univ Turku, Dept Paediat, Turku, Finland
关键词
LYME NEUROBORRELIOSIS; YOUNG-CHILDREN; TETRACYCLINES; TEETH;
D O I
10.1093/jac/dkx245
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The use of doxycycline has been avoided before 8 years of age due to known dental staining caused by tetracyclines, although doxycycline differs from classical tetracyclines in many ways. Doxycycline is still an important antimicrobial agent, but its dental safety is not well studied. Objectives: To examine the state of permanent teeth after doxycycline exposure in children,8 years of age. Methods: Details of doxycycline treatment were collected from medical records. After the eruption of permanent teeth the dental status was examined by an experienced paediatric dentist for detection of dental staining and enamel hypoplasia. The resulting dental photographs were evaluated by a second independent experienced paediatric dentist. Results: The mean age of 38 study subjects at the time of doxycycline treatment was 4.7 years (range 0.6-7.9 years, SD 2.3). The doxycycline dose was 10 mg/kg/day (varying from 8 to 10 mg/kg/day) for the first 2-3 days and 5mg/kg/day (varying from 2.5 to 10mg/kg/day) thereafter. The mean length of the treatment was 12.5days (SD 6.0) and ranged from 2 to 28 days. Tetracycline-like staining or enamel hypoplasia of developing teeth was detected in none of the subjects. Conclusions: Doxycycline treatment of small children does not seem to induce permanent tooth staining.
引用
收藏
页码:2887 / 2890
页数:4
相关论文
共 14 条
[1]   Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines [J].
Agwuh, Kenneth N. ;
MacGowan, Alasdair .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) :256-265
[2]  
[Anonymous], 2015, RED BOOK 2015 REPORT
[3]   Teething issues: can doxycycline be safely used in young children? [J].
Boast, Alison ;
Curtis, Nigel ;
Gwee, Amanda .
ARCHIVES OF DISEASE IN CHILDHOOD, 2016, 101 (08) :772-774
[4]   Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension [J].
Bremell, D. ;
Dotevall, L. .
EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (09) :1162-1167
[5]   Revisiting doxycycline in pregnancy and early childhood - time to rebuild its reputation? [J].
Cross, Ruby ;
Ling, Clare ;
Day, Nicholas P. J. ;
McGready, Rose ;
Paris, Daniel H. .
EXPERT OPINION ON DRUG SAFETY, 2016, 15 (03) :367-382
[6]   Doxycycline for community-acquired pneumonia [J].
Cunha, BA .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (06) :870-870
[7]   PENETRATION OF DOXYCYCLINE INTO CEREBROSPINAL-FLUID IN PATIENTS TREATED FOR SUSPECTED LYME NEUROBORRELIOSIS [J].
DOTEVALL, L ;
HAGBERG, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (07) :1078-1080
[8]  
FORTI G, 1969, LANCET, V1, P782
[9]  
GROSSMAN ER, 1971, PEDIATRICS, V47, P567
[10]  
KRAUS B. S., 1959, JOUR AMER DENTAL ASSOC, V59, P1128